Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport
Drug Testing and Analysis · 2024-08 · 16 (8) · 827-834
DOI: 10.1002/dta.3600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 20.11.2023. Verfasst von Kim Petterson Bohlin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden. Hauptthemen laut MEDLINE: Anabolic Agents, Substance Abuse Detection, Doping in Sports. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Stockholm County Council, Stockholms Läns Landsting.
Abstract (Originalsprache)
Selective androgen receptor modulators (SARMs) are prohibited by the World Anti‐Doping Agency (WADA) since 2008. Similarly, to anabolic androgenic steroids (AAS), SARMs are detrimental to health not only in athletes but also in the general population. However, studies of the occurrence of SARMs outside of sport are scarce. Swedish healthcare samples from the Drugs of Abuse Laboratory at Karolinska were analyzed using WADA‐accredited screening methods at the Doping Control Laboratory in Stockholm to estimate the frequency of SARM use outside of the WADA laboratories. Twenty (4%) of the male urine samples ( n = 542) were positive for SARMs, whereas none of the analyzed female samples ( n = 100) contained any SARMs. The top three SARMs found were LGD‐4033 followed by RAD140 and ostarine. Two or more SARMs were found in >50% of the SARM‐positive samples. AASs were identified in 40% of samples containing SARMs. A difference between genders was observed where 34% male and 7% female samples contained AAS. Many samples displayed testosterone/epitestosterone values indicative of testosterone intake, without presence of other AAS, and hence, there is a risk that these samples are being falsely reported as negative. Our results indicate that SARM use might be a concern outside of sport. Subsequently, in addition to AAS, the healthcare system should also be informed about SARM abuse and the associated adverse side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
- Doping Control Laboratory, Clinical Pharmacology, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
- Drugs of Abuse Laboratory, Clinical Pharmacology, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Kim Petterson Bohlin, Alexander Andersson, Lena Ekström
Förderung
- Stockholm County Council
- Stockholms Läns Landsting
Zitieren
APA
Bohlin, K. P., Pohanka, A., Andersson, A., Villén, T., & Ekström, L. (2024). Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport. Drug Testing and Analysis, 16(8), 827-834. https://doi.org/10.1002/dta.3600
Vancouver
Bohlin KP, Pohanka A, Andersson A, Villén T, Ekström L. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport. Drug Testing and Analysis. 2024;16(8):827-834. doi:10.1002/dta.3600
BibTeX
@article{Bohlin2024,
author = {Bohlin, Kim Petterson and Pohanka, Anton and Andersson, Alexander and Villén, Tomas and Ekström, Lena},
title = {Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport},
journal = {Drug Testing and Analysis},
year = {2024},
volume = {16},
number = {8},
pages = {827--834},
doi = {10.1002/dta.3600}
}
EUVIMED